# Novavax Inc: Form 8-K, filed May 27, 2025

- Company: [Novavax Inc](/companies/nvax.md) (CIK 1000694)
- Form: 8-K
- Filed: 2025-05-27
- Accepted by EDGAR: May 27, 2025, 16:05 ET
- Period: 2025-05-27
- Accession: 0001104659-25-052959
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1000694/000110465925052959/tm2516186d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1000694/000110465925052959/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1000694/000110465925052959/tm2516186d1_8k.htm

Filed May 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-052959. Last ingested by Listed: Nov 5, 2026, 12:23 ET. No prices; not investment advice.